224 related articles for article (PubMed ID: 31151932)
1. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.
Shen Q; Polom K; Williams C; de Oliveira FMS; Guergova-Kuras M; Lisacek F; Karlsson NG; Roviello F; Kamali-Moghaddam M
EBioMedicine; 2019 Jun; 44():322-333. PubMed ID: 31151932
[TBL] [Abstract][Full Text] [Related]
2. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
3. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
[TBL] [Abstract][Full Text] [Related]
4. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer.
Feng T; Jie M; Deng K; Yang J; Jiang H
Clin Chim Acta; 2024 May; 558():119675. PubMed ID: 38631604
[TBL] [Abstract][Full Text] [Related]
5. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
6. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
8. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
11. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
[TBL] [Abstract][Full Text] [Related]
12. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis.
Song Y; Wang J; Sun J; Chen X; Shi J; Wu Z; Yu D; Zhang F; Wang Z
Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):679-695. PubMed ID: 33607292
[TBL] [Abstract][Full Text] [Related]
13. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.
Izumi D; Gao F; Toden S; Sonohara F; Kanda M; Ishimoto T; Kodera Y; Wang X; Baba H; Goel A
EBioMedicine; 2019 Mar; 41():268-275. PubMed ID: 30772302
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of serum LIM homeobox transcription factor 1 alpha in patients with gastric cancer.
Li D; Li C
Medicine (Baltimore); 2019 May; 98(22):e15783. PubMed ID: 31145300
[TBL] [Abstract][Full Text] [Related]
15. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
17. Multiple cytokine profiling in serum for early detection of gastric cancer.
Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
[TBL] [Abstract][Full Text] [Related]
18. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
[TBL] [Abstract][Full Text] [Related]
19. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Tian R; Hu J; Ma X; Liang L; Guo S
Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
[TBL] [Abstract][Full Text] [Related]
20. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]